Page 45 - TD-1-1

Tumor Discovery A bioinformatics analysis of PD-1 in cancers

Figure 2. Prognostic value of PD-1 mRNA expression in breast cancer patients. HR, hazard ratio.

patients with medium-differentiated liver cancer might be of PD-1 to liver cancer cell-surface PD-L1 results in the
the most potential subjects for receiving anti-PD-1/PD-L1 release of inhibitory signals, negative regulation, inhibition
treatment [23,24] . Furthermore, in the peripheral blood of of lymphatic cell-mediated immune response, and apoptosis
patients with primary liver cancer, the expression of PD-1 of specific cytotoxic T lymphocytes, thereby aiding tumor
was higher than that of the control group. The binding cells evade immunization recognition and removal and

Volume 1 Issue 1 (2022) 6 https://doi.org/10.36922/td.v1i1.59